...
首页> 外文期刊>Investigative ophthalmology & visual science >Inhibitory Effect of Aminoimidazole Carboxamide Ribonucleotide (AICAR) on Endotoxin-Induced Uveitis in Rats
【24h】

Inhibitory Effect of Aminoimidazole Carboxamide Ribonucleotide (AICAR) on Endotoxin-Induced Uveitis in Rats

机译:氨基咪唑羧酰胺核糖核苷酸(AICAR)对内毒素性葡萄膜炎的抑制作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose.: To investigate the anti-inflammatory effect of aminoimidazole carboxamide ribonucleotide (AICAR), an analog of adenosine monophosphate (AMP), in endotoxin-induced uveitis (EIU). Methods.: EIU was induced by subcutaneous injection of lipopolysaccharide (LPS) (200 ??g) in Lewis rats. AICAR (50 mg/kg, intraperitoneally) was given 6 hours prior and at the same time as LPS injection. Clinical uveitis scores, number of anterior chamber (AC) infiltrating cells, anterior chamber protein concentration, retinal vessel leukocyte adhesion, and protein leakage were measured 24 hours later. Protein levels of C-C chemokine ligand-2 (CCL-2)/monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-?± (TNF-?±) and intercellular adhesion molecule-1 (ICAM-1) in aqueous humor and retina and nuclear translocation of nuclear factora???oB (NF-?oB) in the retina were determined by enzyme-linked immunosorbent assay (ELISA). Both mRNA and protein levels of CD14 in peripheral blood mononuclear cells were also measured. Results.: AICAR treatment significantly reduced EIU clinical severity as well as inflammatory cell infiltration and protein concentration in aqueous humor. Similarly, the number of retinal vessel-adherent leukocytes and protein leakage were decreased by AICAR treatment. Protein levels of TNF-?±, CCL-2/MCP-1, and ICAM-1 in aqueous humor and CCL-2/MCP-1 and ICAM-1 levels in retina were suppressed with AICAR treatment. AICAR also reduced NF-?oB translocation and CD14 expression. Conclusions.: AICAR reduces systemic LPS susceptibility and attenuates intraocular inflammation in a rat EIU model by limiting infiltration of leukocytes, suppressing inflammatory mediators, and inhibiting the NF-?oB pathway.
机译:目的:研究氨基磷酸咪唑(AMP)的类似物氨基咪唑羧酰胺核糖核苷酸(AICAR)对内毒素性葡萄膜炎(EIU)的抗炎作用。方法:通过在Lewis大鼠中皮下注射脂多糖(LPS)(200μg)诱导EIU。在LPS注射之前和同时给予AICAR(50 mg / kg,腹膜内)。 24小时后测定临床葡萄膜炎评分,前房(AC)浸润细胞数,前房蛋白浓度,视网膜血管白细胞粘附和蛋白渗漏。水溶液中CC趋化因子配体2(CCL-2)/单核细胞趋化蛋白1(MCP-1),肿瘤坏死因子-α±(TNF-α±)和细胞间粘附分子1(ICAM-1)的蛋白水平通过酶联免疫吸附测定(ELISA)测定视网膜中的幽默和视网膜以及核因子αoB(NF-βoB)的核易位。还测量了外周血单核细胞中CD14的mRNA和蛋白水平。结果:AICAR治疗可显着降低EIU临床严重程度以及房水中的炎症细胞浸润和蛋白质浓度。类似地,通过AICAR治疗,视网膜血管粘附白细胞的数量和蛋白质泄漏减少。 AICAR治疗可抑制房水中TNF-α±,CCL-2 / MCP-1和ICAM-1的蛋白水平,以及视网膜中CCL-2 / MCP-1和ICAM-1的蛋白水平。 AICAR还减少了NF-κB易位和CD14表达。结论:AICAR通过限制白细胞浸润,抑制炎性介质并抑制NF-κB通路,降低了大鼠EIU模型的系统性LPS敏感性并减轻了眼内炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号